Navigation Links
Chief Technology Officer Joins ACAMP
Date:9/22/2008

EDMONTON, AB, Sept. 22 /PRNewswire/ - ACAMP Alberta Centre for Advanced MNT (Microsystems and Nanotechnology) Products is pleased to announce the appointment of Dr. Kevin Yallup as Chief Technology Officer. In this new role Dr. Yallup will lead the product development effort within ACAMP to build a world-class capability in Alberta for the packaging and assembly of micro- and nano-scale technology devices, turning them into market-ready commercial or industrial products and applications.

"We are very pleased Kevin joined our team", said Ken Brizel CEO ACAMP, "Kevin brings over 15 years experience in MNT product development from Europe to Alberta. In this role, Kevin will lead the ACAMP engineering team in supporting companies producing MNT products, through consultation, hands on design and development of state of the art packaging and assembly technologies."

Dr. Yallup has been a key contributor and the project leader on the original study in the development of ACAMP. Dr. Yallup has a broad engineering experience in MNT products, prior to joining ACAMP, he has held engineering management roles in Technology for Industry Ltd., CDT Ltd., Kymata Ltd., BCO Technologies (NI) Ltd., National Semiconductor and Analog Devices. Dr Yallup graduated from Cambridge University, UK with a degree in Natural Sciences, specializing in solid state physics.

"I am extremely excited to join ACAMP in this new role and eager to help shorten the path to commercialization for MNT companies." said Dr. Kevin Yallup, CTO ACAMP," Product development, packaging and assembly of MNT products are my focus supporting companies throughout the region."

Yallup's initial focus will be to provide practical industrial engineering support, purchase specific equipment and hire and help train the engineers needed to complete the team. ACAMP has established a class 1000 clean room, wet lab, metrology and test lab. State of the art assembly and packaging equipment is being put in place over the remainder of 2008 and beginning of 2009 including laser dicing, probers, gluing stations, Flip-Chip bonding and a host of test and reliability equipment which will facilitate the challenge of packaging micro and nano-products for prototyping and volume production for applications in energy, biomedical, agriculture, the environment, and information and communications technology.

ACAMP is the result of a collaborative effort between industry, government and academia to create a path to commercialization for established firms, small start-up companies and researchers in the microsystems and nanotechnology (MNT) sector. ACAMP is a not-for-profit company that provides support in three critical areas of commercialization: marketing & business development, product development and packaging and assembly.


'/>"/>
SOURCE ACAMP
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
2. Algenol Biofuels Appoints Chief Science Officer
3. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
5. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
6. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
7. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
8. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
9. Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
10. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
11. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... portfolio company, today announced it has acquired the assets of Theorem Clinical ... International and focuses on clinical trial drug packaging, labeling, storage, reconciliation, and ...
(Date:12/6/2016)... Ind. , Dec. 6, 2016 Zimmer ... "Company") today announced the pricing terms of its ... to $1.25 billion aggregate purchase price (excluding accrued and ... settlement date and excluding fees and expenses related ... the debt securities identified in the table below ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
Breaking Biology Technology:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
(Date:6/27/2016)... Research and Markets has announced the addition of the "Biometrics ... The report forecasts the biometrics market ... CAGR of 12.28% during the period 2016-2020. The ... inputs from industry experts. The report covers the market landscape and ... a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):